A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches
The potential to emulate or enhance antibodies with nucleic acid aptamers while lowering costs has prompted development of new aptamer-protein, siRNA, drug, and nanoparticle conjugates. Specific focal points of this review discuss DNA aptamers covalently bound at their 3' ends to various pr...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/6/3/340 |